World's Best Scientists 2026 revealed!
VIEW LIST
Franck Morschhauser

Franck Morschhauser

University of Lille
France

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 94 10370 9735 324 307 883 37993

Franck Morschhauser publications per year

The chart shows the history of publications by Franck Morschhauser between 1995 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Franck Morschhauser published across 31 years, from 1995 to 2025, averaging 29.6 papers a year. Output peaked at 140 publications in 2023. 159 of the 918 publications appeared in the last two years.

No. of publications
25 50 75 100 125
Bar chart. Horizontal axis: year, 1995 to 2025. Vertical axis: number of publications, 0 to 140. Peak 140 publications in 2023. 1995: 1 publication 1996: 0 publications 1997: 2 publications 1998: 1 publication 1999: 1 publication 2000: 0 publications 2001: 2 publications 2002: 1 publication 2003: 4 publications 2004: 8 publications 2005: 10 publications 2006: 7 publications 2007: 21 publications 2008: 19 publications 2009: 15 publications 2010: 24 publications 2011: 24 publications 2012: 23 publications 2013: 27 publications 2014: 32 publications 2015: 28 publications 2016: 36 publications 2017: 55 publications 2018: 46 publications 2019: 44 publications 2020: 46 publications 2021: 79 publications 2022: 63 publications 2023: 140 publications 2024: 66 publications 2025: 93 publications
1995 2025

918 publications in total across all disciplines

View publications per year as a table
Franck Morschhauser: publications per year, 1995 to 2025
Year Publications
1995 1
1996 0
1997 2
1998 1
1999 1
2000 0
2001 2
2002 1
2003 4
2004 8
2005 10
2006 7
2007 21
2008 19
2009 15
2010 24
2011 24
2012 23
2013 27
2014 32
2015 28
2016 36
2017 55
2018 46
2019 44
2020 46
2021 79
2022 63
2023 140
2024 66
2025 93
Total 918
Download as CSV

Franck Morschhauser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Franck Morschhauser sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 881–900 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 883 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139 883
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Franck Morschhauser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Franck Morschhauser sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 94
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Franck Morschhauser is affiliated with the University of Lille in France. Their research primarily focuses on fields within medicine, with notable contributions in pathology and forensic medicine, oncology, genetics, molecular biology, and immunology.

The scientist's work extensively covers several specialized topics, including:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • Monoclonal and Polyclonal Antibodies Research

Franck Morschhauser has published papers in some of the leading oncology and hematology journals. Frequent venues for their publications include:

  • Blood
  • Hematological Oncology
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances

Co-authorship is a significant element in their research output. Key frequent co-authors are:

  • Emmanuel Bachy
  • Guillaume Cartron
  • Olivier Casasnovas
  • Catherine Thiéblemont
  • Roch Houot

Among notable papers authored or co-authored by Franck Morschhauser are:

  • "The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee" (2022, Blood)
  • "Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial" (2022, The Lancet)
  • "Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (2022, New England Journal of Medicine)
  • "Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial" (2020, The Lancet Oncology)
  • "Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma" (2021, New England Journal of Medicine)

Best Publications

  • Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    P Feugier;A. Van Hoof;C. Sebban;P. Solal-Celigny

  • Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

    Bertrand Coiffier;Barbara Pro;H. Miles Prince;Francine Foss

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

    Franck Morschhauser;John Radford;Achiel Van Hoof;Umberto Vitolo

  • Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

    Gilles Salles;Nicolas Mounier;Sophie de Guibert;Franck Morschhauser

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

    Ralf Trappe;Stephan Oertel;Veronique Leblond;Peter Mollee

  • Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

    Arnaud Jaccard;Nathalie Gachard;Benoit Marin;Sylvie Rogez

  • Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

    Michael Wang;Simon Rule;Pier Luigi Zinzani;Andre Goy

  • Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.

    Franck Morschhauser;Hervé Tilly;Aristeidis Chaidos;Pamela McKay

  • Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    Sandy Amorim;Anastasios Stathis;Mary Gleeson;Sunil Iyengar

  • Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

    Steven Le Gouill;Catherine Thieblemont;Lucie Oberic;Anne Moreau

  • Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.

    Martin Dreyling;Armando Santoro;Luigina Mollica;Sirpa Leppä

  • Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    Maria Corinna A Palanca-Wessels;Myron Czuczman;Gilles Salles;Sarit Assouline

  • Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study

    Anas Younes;Catherine Thieblemont;Franck Morschhauser;Ian Flinn

  • Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma

    John G. Gribben;Nathan Fowler;Franck Morschhauser

  • Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    Franck Morschhauser;Nathan Fowler;Pierre Feugier;Reda Bouabdallah

  • SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

    René-Olivier Casasnovas;Michel Meignan;Alina Berriolo-Riedinger;Stéphane Bardet

  • A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.

    Harriet S. Walter;Simon A. Rule;Martin J. S. Dyer;Lionel Karlin

  • Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

    Christian Récher;Bertrand Coiffier;Corinne Haioun;Thierry Jo Molina

Frequent Co-Authors

Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
John Radford
John Radford University of Manchester
Ryan D. Morin
Ryan D. Morin Simon Fraser University
Ranjana H. Advani
Ranjana H. Advani Stanford University
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
Pauline Brice
Pauline Brice Hôpital Saint-Louis
Peter Vandenberghe
Peter Vandenberghe KU Leuven
Peter Johnson
Peter Johnson University of Southampton
Eric Oksenhendler
Eric Oksenhendler Université Paris Cité
Olivier Casasnovas
Olivier Casasnovas Grenoble Alpes University

External Links

Personal website of Franck Morschhauser

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but want to explore alternative or supporting careers in healthcare, several online degree programs offer flexible and affordable options. These pathways can provide valuable credentials and open doors to essential medical roles.

For those drawn to the data side of healthcare, pursuing an online mhi (Master’s in Health Information) degree is a great step. This field focuses on managing patient data and health information systems.

Students seeking entry-level roles should consider affordable medical billing and coding programs. These programs prepare you for fast-growing jobs handling crucial administrative functions in medical settings.

For those interested in nursing careers, you’ll find a range of cheap online nursing programs for RN degrees. If you want to advance and become a nurse practitioner, check out the cheapest online fnp program options for a graduate degree.

These related online programs make it easier to progress in healthcare—no matter your background or budget.

Best Scientists Citing Franck Morschhauser

Gilles Salles

Gilles Salles

Memorial Sloan Kettering Cancer Center

Publications: 5

Ari Melnick

Ari Melnick

Cornell University

Publications: 3

Catherine Thieblemont

Catherine Thieblemont

Université Paris Cité

Publications: 2

Emanuele Zucca

Emanuele Zucca

Universita della Svizzera Italiana

Publications: 2

Anas Younes

Anas Younes

AstraZeneca (United Kingdom)

Publications: 2

John F. Seymour

John F. Seymour

Peter MacCallum Cancer Centre

Publications: 2

Housheng Hansen He

Housheng Hansen He

University of Toronto

Publications: 2

Jude Fitzgibbon

Jude Fitzgibbon

Queen Mary University of London

Publications: 2

Laura Pasqualucci

Laura Pasqualucci

Columbia University

Publications: 2

Gilbert G. Privé

Gilbert G. Privé

University of Toronto

Publications: 2

Peter Johnson

Peter Johnson

University of Southampton

Publications: 2

Andreas Engert

Andreas Engert

University of Cologne

Publications: 2

Jean-Charles Soria

Jean-Charles Soria

Amgen (United States)

Publications: 2

Frederic Davi

Frederic Davi

Assistance Publique – Hôpitaux de Paris

Publications: 1

Graham Packham

Graham Packham

University of Southampton

Publications: 1

Anthony Letai

Anthony Letai

Harvard University

Publications: 1

Trending Scientists

Abdullahi Yusuf

Abdullahi Yusuf

Biruni University

Josephine B. Chang

Josephine B. Chang

Northrop Grumman (United States)

Tom Hildebrandt

Tom Hildebrandt

Icahn School of Medicine at Mount Sinai

Patrick M. Fisher

Patrick M. Fisher

Copenhagen University Hospital

José M. Guerra-García

José M. Guerra-García

University of Seville

Shile Huang

Shile Huang

Louisiana State University Health Sciences Center Shreveport

Shigeyuki Wakitani

Shigeyuki Wakitani

Mukogawa Women's University

Scott I. Simon

Scott I. Simon

University of California, Davis

Simon Øverland

Simon Øverland

Norwegian Institute of Public Health

Daniel Grosjean

Daniel Grosjean

California Institute of Technology

Hongshun Yang

Hongshun Yang

National University of Singapore

Christian Rolando

Christian Rolando

University of Lille

Robert E. Booth

Robert E. Booth

University of Colorado Denver

R Andrew Moore

R Andrew Moore

University of Oxford

Bernardo R. Broitman

Bernardo R. Broitman

Adolfo Ibáñez University

Minping Wan

Minping Wan

Southern University of Science and Technology

Related Medicine Rankings & Guides

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Virginia – Accredited ADN, BSN, MSN Programs
2027 Best Online MSN in Health/Nursing Informatics Programs

2027 Best Online MSN in Health/Nursing Informatics Programs
2027 Easiest Direct-Entry MSN Programs to Get Into

2027 Easiest Direct-Entry MSN Programs to Get Into
2027 Easiest Nurse Practitioner Specialty Programs to Get Into

2027 Easiest Nurse Practitioner Specialty Programs to Get Into
2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Washington: Accredited RN to BSN Programs
2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Oklahoma – Accredited Schools Online & Campus
2027 Most Affordable Online FNP Programs

2027 Most Affordable Online FNP Programs
2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference

2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference
2027 Fastest Online MSN in Nurse Midwifery Programs

2027 Fastest Online MSN in Nurse Midwifery Programs
2027 Fastest Online Exercise Science Degree Programs

2027 Fastest Online Exercise Science Degree Programs
2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Fastest Online Nutrition Degree Programs

2027 Fastest Online Nutrition Degree Programs
2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Best Online MSN in Forensic Nursing Programs

2027 Best Online MSN in Forensic Nursing Programs
2027 Best Pathways to Pursue MSN without a BSN Degree

2027 Best Pathways to Pursue MSN without a BSN Degree
2027 Best Online Nursing Programs in Ohio – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Ohio – Accredited RN to BSN Programs
2027 Easiest RN-to-MSN Online Programs to Get Into

2027 Easiest RN-to-MSN Online Programs to Get Into
2027 Fastest Online Surgical Tech Certificate Programs

2027 Fastest Online Surgical Tech Certificate Programs
2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus
2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Utah – Accredited ADN, BSN & MSN Programs
2027 CMAA vs. CCMA Certification: Explaining the Difference

2027 CMAA vs. CCMA Certification: Explaining the Difference

Recently Published Articles

2027 Security Software Developer Careers: Skills, Education, Salary & Job Outlook

2027 Security Software Developer Careers: Skills, Education, Salary & Job Outlook
2027 Military-Friendly Online Adult Gerontology Acute Care Nurse Practitioner Master's Degree Programs: Benefits, Accreditation & Career Outcomes

2027 Military-Friendly Online Adult Gerontology Acute Care Nurse Practitioner Master's Degree Programs: Benefits, Accreditation & Career Outcomes
2027 Best PsyD Programs in Kentucky: APA Accredited Online & Campus

2027 Best PsyD Programs in Kentucky: APA Accredited Online & Campus
2027 LPC Counseling Licensure Requirements in Texas

2027 LPC Counseling Licensure Requirements in Texas
2027 Competency-Based Online Human Services Master's Degrees

2027 Competency-Based Online Human Services Master's Degrees
2027 Is a General Studies Degree Worth It

2027 Is a General Studies Degree Worth It
2027 Best Online Ministry Leadership Doctorate Programs for Consulting Careers

2027 Best Online Ministry Leadership Doctorate Programs for Consulting Careers
2027 Fastest Online Addiction Counseling Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Addiction Counseling Master's Degree Programs You Can Finish in Under 2 Years
2027 How to Become an Elementary School Teacher in Massachusetts: Requirements & Certification

2027 How to Become an Elementary School Teacher in Massachusetts: Requirements & Certification
2027 How to Become a Licensed Therapist (LPC) in San Antonio, TX

2027 How to Become a Licensed Therapist (LPC) in San Antonio, TX
2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Science Degree Master's Program?

2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Science Degree Master's Program?
2027 Online Business Administration Degrees With Project Management Concentrations

2027 Online Business Administration Degrees With Project Management Concentrations
2027 Best Online Computer Engineering Degree Programs

2027 Best Online Computer Engineering Degree Programs
2027 MBA vs. Master's in Social Work: Which Drives Better Career Outcomes

2027 MBA vs. Master's in Social Work: Which Drives Better Career Outcomes
2027 How to Become a Mental Health Counselor in El Paso, TX: Education Requirements & Certification

2027 How to Become a Mental Health Counselor in El Paso, TX: Education Requirements & Certification
2027 How to Become a Hospital CEO: Salary & Career Paths

2027 How to Become a Hospital CEO: Salary & Career Paths
2027 How to Become an Art Teacher in Delaware: Requirements & Certification

2027 How to Become an Art Teacher in Delaware: Requirements & Certification
2027 Best BSN to DNP Programs in Oregon: Online & Campus

2027 Best BSN to DNP Programs in Oregon: Online & Campus
2027 Should You Get an MBA Right After College

2027 Should You Get an MBA Right After College
2027 How to Become an Elementary School Teacher in New York: Requirements & Certification

2027 How to Become an Elementary School Teacher in New York: Requirements & Certification
2027 Best Online Journalism Degree Master's Programs for Career Changers

2027 Best Online Journalism Degree Master's Programs for Career Changers